CompletedNot Applicable

The Efficiency of Chest Physiotherapy Applied in a Different Order

Turkey (Türkiye)42 participantsStarted 2022-01-20

Plain-language summary

This study intends to compare the impact of chest physiotherapy applied with two different methods on physiologic parameters in children hospitalized in the intensive care unit. In the intensive care unit where the study was conducted, the patients who have a respiratory disorder and receive supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask are first administered an inhaler drug therapy placed in the physician's order. It is followed by chest physiotherapy and then oropharyngeal and nasopharyngeal aspiration. However, in practice rendered by the researcher, it is suggested that when chest physiotherapy and aspiration are administered in the first place and then followed by an inhaler drug therapy, it might have a more positive impact on the patient's physiologic parameters. For this reason, it is intended to compare the efficiency of chest physiotherapy applied in a different order.

Who can participate

Age range

1 Month – 6 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hospitalized patients at Cerrahpaşa Faculty of Medicine Pediatric Intensive Care Unit 1, * Aged between 1 months-6 years, * Having been in intensive care for at least two days, * Concious pediatric patient, * Receiving supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask, * Being administered chest physiotherapy (Tapotement or Vibration), * Being administered oropharyngeal and nasopharyngeal aspiration, * Inhaler drug therapy included in the patient's order, * Parents, volunteering for the study. Exclusion Criteria: * Parents not volunteering for the study, * Patients younger than 1-month or older than 6-years old, * Not receiving supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask * Not being administered oropharyngeal and nasopharyngeal aspiration, * Inhaler drug therapy is not included in the physician's order.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Physiological Parameter Assessment Form Showing The Change In Heart Rate

Timeframe: This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged.

Trial details

NCT IDNCT05022082

SponsorSelmin Kose

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-11-04

View on ClinicalTrials.gov More Respiratory Disease trials